Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
出版年份 2022 全文链接
标题
Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
作者
关键词
-
出版物
Multiple Sclerosis and Related Disorders
Volume 68, Issue -, Pages 104167
出版商
Elsevier BV
发表日期
2022-09-15
DOI
10.1016/j.msard.2022.104167
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran
- (2022) Seyed Massood Nabavi et al. Vaccines
- Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis
- (2022) Ethel Ciampi et al. Multiple Sclerosis and Related Disorders
- COVID-19 vaccine associated demyelination & its association with MOG antibody
- (2022) M. Netravathi et al. Multiple Sclerosis and Related Disorders
- COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021
- (2021) Anat Achiron et al. Multiple Sclerosis Journal
- Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
- (2021) Caroline Papeix et al. Multiple Sclerosis Journal
- Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
- (2021) Ian McDonald et al. npj Vaccines
- Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
- (2021) Patricia K. Coyle et al. ADVANCES IN THERAPY
- Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
- (2021) Itay Lotan et al. EUROPEAN JOURNAL OF NEUROLOGY
- A case of longitudinally extensive transverse myelitis following vaccination against Covid-19
- (2021) Claudia Pagenkopf et al. JOURNAL OF NEUROIMMUNOLOGY
- Vaccination and multiple sclerosis in the era of the COVID-19 pandemic
- (2021) Tobias Monschein et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey
- (2021) Lauren Uhr et al. Multiple Sclerosis Journal
- Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19
- (2021) Shuai Chen et al. NEUROLOGICAL SCIENCES
- Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
- (2021) Mohammad Ali Sahraian et al. VACCINE
- COVID-19 Vaccination Attitudes With Neuromyelitis Optica Spectrum Disorders: Vaccine Hesitancy and Coping Style
- (2021) Yafang Xu et al. Frontiers in Neurology
- Mortality of neuromyelitis optica spectrum disorders in a Chinese population
- (2021) Qin Du et al. Annals of Clinical and Translational Neurology
- Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
- (2021) Raches Ella et al. LANCET
- Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey
- (2021) Yun Huang et al. Multiple Sclerosis and Related Disorders
- New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19
- (2021) Yara D Fragoso et al. Multiple Sclerosis and Related Disorders
- COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders
- (2021) Vanja Jovicevic et al. Multiple Sclerosis and Related Disorders
- ¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis
- (2021) Gloria Michelena et al. Multiple Sclerosis and Related Disorders
- Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases
- (2021) Itay Lotan et al. Multiple Sclerosis and Related Disorders
- Post COVID-19 vaccination neuromyelitis optica spectrum disorder: Case report & MRI findings
- (2021) Noor Badrawi et al. Radiology Case Reports
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic
- (2020) Hesham Abboud et al. Multiple Sclerosis and Related Disorders
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China
- (2020) Yulan Lin et al. PLoS Neglected Tropical Diseases
- Effects of immunotherapies and prognostic predictors in neuromyelitis optica spectrum disorder: a prospective cohort study
- (2019) Ziyan Shi et al. JOURNAL OF NEUROLOGY
- Addressing Vaccine Hesitancy in China: A Scoping Review of Chinese Scholarship
- (2019) Ronghui Yang et al. Vaccines
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
- (2017) Jan-Patrick Stellmann et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Comparison of Propensity Score Methods and Covariate Adjustment
- (2017) Markus C. Elze et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
- (2016) Ilya Kister et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Health insurance affects the use of disease-modifying therapy in multiple sclerosis
- (2016) Guoqiao Wang et al. NEUROLOGY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Vaccine hesitancy: Definition, scope and determinants
- (2015) Noni E. MacDonald VACCINE
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Infections and autoimmunity – friends or foes?
- (2009) Shaye Kivity et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started